John Beveridge will be subject to election at the next annual shareholder meeting, scheduled to be on November 7.
Aroa Biosurgery is looking to accelerate its US growth.
The newly created specialist role is part of the strategy to expand investment capabilities and investment management services.
He replaces Dan Coup, who is now chief executive of the QE II National Trust.
Shelley Ruha will chair the audit and risk committee.
Specialist consultancy appoints Andy Hargrave.
Geoffory Rimmer and Robert Sloan appointed to drive growth strategy.
Fraser Whineray has been appointed chief operating officer.
TBWA NZ Group managing director becomes chief executive.
AI technology leader Jens Meggers joins the global SaaS provider.
